
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Alcon raises offer in amended deal to acquire STAAR Surgical
3
Neurotrophic keratitis outcomes improve with early, stage-based care
4
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
5








.png)


